Adrian Mills
CHIEF BUSINESS OFFICER
Adrian Mills
Novimmune
Switzerland
Biography
Adrian Mills joined Novimmune in July 2014 after an extensive career with GSK. Most recently he was their EU Commercial Director in the Rare & Critical Diseases Business Unit where he was responsible for launching new orphan medicines for neuromuscular disorders, metabolic diseases and immuno-deficiencies, as well as leading the European rare diseases sales and marketing teams promoting a portfolio of orphan and critical care medicines. Adrian's professional background includes launching new medicines and negotiating market access and pricing hurdles in Europe, Japan, Latin America and North America. With over 20 years experience in life sciences, Adrian has led commercial functions in both R&D, strategy development and commercial operations. Prior to GSK, he worked in consulting (Booz & Co) and investment banking (Schroders) advising life sciences companies. Adrian holds an M.A. (Hons) in Engineering from Queens' College, Cambridge, and an MBA from the London Business School.
Research Interest
Rare & Critical Diseases Business
